Immune gene expression in primary melanomas to predict lower risk of recurrence and death.
Sivendran S, Chang R, Harcharik S, Hall L, Bernardo S, Moskalenko M, Phelps R, Sivendran M, Cohain A, DiFeo A, Parides M, Lebwohl M, Friedlander P, Banchereau J, Bhardwaj N, Oh W, Burakoff S, Palucka K, Merad M, Saenger Y. Immune gene expression in primary melanomas to predict lower risk of recurrence and death. Journal Of Clinical Oncology 2013, 31: 3014-3014. DOI: 10.1200/jco.2013.31.15_suppl.3014.Peer-Reviewed Original ResearchPrediction of non-recurrenceIndependent patient cohortReceiver Operating CharacteristicProlonged survivalMRNA copy numberNon-recurrenceTraining cohortPatient cohortGene panelLow risk of recurrencePrimary human melanomaStandard prognostic indicatorsImmune-related genesRisk of recurrenceReceiver operating characteristic curvePrimary melanomaImmunotherapy studiesMelanoma recurrencePrognostic indicatorImmune biomarkersRecurrence riskMitotic rateHuman melanomaPrevent recurrencePatient stratification
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply